Researchers at the University of Illinois at Chicago and Queensland University of Technology of Australia, have developed a device that can isolate individual cancer cells from patient blood samples.
The microfluidic device works by separating the various cell types found in blood by their size. The device may one day enable rapid, cheap liquid biopsies to help detect cancer and develop targeted treatment plans. The findings are reported in the journal Microsystems & Nanoengineering.
“This new microfluidics chip lets us separate cancer cells from whole blood or minimally-diluted blood,” said Ian Papautsky, the Richard and Loan Hill Professor of Bioengineering in the UIC College of Engineering and corresponding author on the paper. “While devices for detecting cancer cells circulating in the blood are becoming available, most are relatively expensive and are out of reach of many research labs or hospitals. Our device is cheap, and doesn’t require much specimen preparation or dilution, making it fast and easy to use.”
The ability to successfully isolate cancer cells is a crucial step in enabling liquid biopsy where cancer could be detected through a simple blood draw. This would eliminate the discomfort and cost of tissue biopsies which use needles or surgical procedures as part of cancer diagnosis. Liquid biopsy could also be useful in tracking the efficacy of chemotherapy over the course of time, and for detecting cancer in organs difficult to access through traditional biopsy techniques, including the brain and lungs.
However, isolating circulating tumor cells from the blood is no easy task, since they are present in extremely small quantities. For many cancers, circulating cells are present at levels close to one per 1 billion blood cells. “A 7.5-milliliter tube of blood, which is a typical volume for a blood draw, might have ten cancer cells and 35-40 billion blood cells,” said Papautsky. “So we are really looking for a needle in a haystack.”
Microfluidic technologies present an alternative to traditional methods of cell detection in fluids. These devices either use markers to capture targeted cells as they float by, or they take advantage of the physical properties of targeted cells — mainly size — to separate them from other cells present in fluids.
Papautsky and his colleagues developed a device that uses size to separate tumor cells from blood. “Using size differences to separate cell types within a fluid is much easier than affinity separation which uses ‘sticky’ tags that capture the right cell type as it goes by,” said Papautsky. “Affinity separation also requires a lot of advanced purification work which size separation techniques don’t need.”
Learn more: New microfluidics device can detect cancer cells in blood
The Latest on: Cancer blood test
[google_news title=”” keyword=”cancer blood test” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cancer blood test
- The FDA Will Test You Nowon May 2, 2024 at 1:42 pm
The agency makes a power grab to regulate lab tests like medical devices.
- Cancer Supertests Are Hereon May 2, 2024 at 8:12 am
Multi-cancer-screening tools—or “ cancer-finding supertests ,” as Galleri has been called— aren’t yet endorsed by the U.S. Preventive Services Task Force, or formally approved by the Food and Drug ...
- Could blood tests make early stage cancer diagnosis accessible?on May 2, 2024 at 12:55 am
A U.S. company is developing a blood test to detect 18 types of cancers. But there is still work ahead to prove its value.
- Artificial intelligence could help diagnose cancer with one spot of dried bloodon May 1, 2024 at 2:32 pm
Scientists in China have created a test using artificial intelligence that can detect cancer using one spot of dried blood.
- Dallas’ Breakthrough Blood Test for Canceron April 30, 2024 at 7:18 pm
A North Dallas diagnostic firm may be on the verge of revolutionizing the cancer screening process. Cancer Check Labs has developed a technology that can screen 40ml of blood and detect the growth of ...
- AI tool may help detect cancer in a few minutes with a drop of bloodon April 29, 2024 at 7:57 am
An AI-powered tool may be able to detect pancreatic, gastric, or colorectal cancer with a sensitivity of 82–100% and takes just a few minutes, a new study indicates.
- New blood test shows promise in early detection of ovarian canceron April 28, 2024 at 7:28 pm
A study reveals that glycoproteins in blood could be key biomarkers for early detection and staging of epithelial ovarian cancer, potentially allowing diagnosis through a simple blood test.
- Balancing hope and reality: The promise and peril of blood-based colorectal cancer screeningon April 24, 2024 at 1:30 am
A simple blood test to detect colorectal cancer sounds amazing. But unlike colonoscopy, a blood test can't remove precancerous polyps.
- AI-powered tool detects cancer in minutes with one drop of bloodon April 23, 2024 at 6:52 am
Scientists in China have developed a test that detects three types of cancers with just one spot of dried blood.
- Researchers developing new colon cancer tests amid rising caseson April 23, 2024 at 3:01 am
With more than 200,000 cases of colon cancer diagnosed across the country every year, researchers are working on new ways to detect the disease better.
via Bing News